Earnings Preview: Trxade Health
Portfolio Pulse from Benzinga Insights
Trxade Health (NASDAQ:MEDS) is set to release its latest quarterly earnings report on August 14, 2023. Analysts estimate an earnings per share (EPS) of $-0.75. The company's past performance shows a trend of beating EPS estimates but experiencing a drop in share price. The stock is currently trading at $9.0, down 59.52% over the last 52-week period.
August 11, 2023 | 4:02 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Trxade Health is expected to report an EPS of $-0.75. Despite beating EPS estimates in the past, the company's share price has typically dropped. The stock is down 59.52% over the last year.
Trxade Health has a history of beating EPS estimates but this has not translated into positive stock performance. In fact, the share price has typically dropped following earnings announcements. Given this trend and the negative returns over the past year, the upcoming earnings report is likely to have a negative impact on the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100